Bernardino Clavo, MD, PhD clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.

1. Notable

   EPOOzo-2 · Patients Referred to the Chronic Pain Unit for…EPOOzo-2 · Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029

   Recruitment opened

   Bernardino Clavo, MD, PhD·Not specified· NCT07325851· Registry history of NCT07325851 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

2. Notable

   MicrOGineTox · Gut Microbiome in Gynecological Cancer · Pelvic…MicrOGineTox · Gut Microbiome in Gynecological Cancer · Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)

   Recruitment opened

   Bernardino Clavo, MD, PhD·Not specified· NCT07259681· Registry history of NCT07259681 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.